Literature DB >> 26622584

Expression of wingless-type mouse mammary tumor virus integration site family pathway effectors in lymphatic and hepatic metastases of patients with colorectal cancer: Associations with the primary tumor.

Sebastian Kraus1, Christian Vay1, Stephan Baldus2, Wolfram T Knoefel1, Nikolas H Stoecklein1, Daniel Vallbohmer1.   

Abstract

The wingless-type mouse mammary tumor virus integration site family (Wnt) pathway plays a major role in the carcinogenesis of colorectal cancer (CRC). Its most important effector, the nuclear β-catenin, influences not only transcription but also the proliferation and dedifferentiation of the colonic mucosa. This induces an epithelial-mesenchymal transition which ultimately can lead to the development of cancer and the formation of metastases. However, little is known about the exact interaction and context-sensitive expression of Wnt-pathway effectors in the primary tumor and corresponding metastasis. Therefore, this study assessed the expression of the three most important effectors of the Wnt pathway, β-catenin, adenomatous polyposis coli (APC) and Wnt-1, in the primary tumor and corresponding metastasis of patients with CRC. Immunohistochemical staining of β-catenin, APC and Wnt-1 was performed in paraffin-embedded tissue samples of the primary tumor, and the corresponding hepatic and nodal metastasis samples from 24 patients with metastatic CRC. Isotype antibodies were used as negative controls. The results were visualized using the ABC-method. Analysis of the primary tumor comprised of a separate evaluation of the central tumor area as well as the invasion front. There was a significant overexpression of nuclear β-catenin at the tumor invasion front (P<0.001). Compared to normal colonic mucosa, expression of cytoplasmic β-catenin was significantly higher in the primary tumor (P<0.001) as well as all the corresponding hepatic and lymphatic metastases (hepatic metastases, P=0.001; nodal metastases, P=0.017). By contrast, APC expression was significantly lower in all analyzed tumor compartments compared with normal colonic mucosa (primary tumor, P=0.022; hepatic metastases, P=0.006; nodal metastases, P=0.012). Finally, Wnt-1 protein expression was significantly lower in liver metastases but not in the primary tumor or lymphatic metastases compared with normal colonic mucosa (P=0.003). The present study demonstrates that the major Wnt-effector proteins, β-catenin, APC and Wnt-1, are heterogeneously expressed in the primary tumor and corresponding hepatic as well as nodal metastases of patients with CRC. This context-sensitive diverse expression of Wnt-effector proteins may be important for future individualized targeted therapies.

Entities:  

Keywords:  colorectal cancer; distant metastases; primary tumor; wingless-type mouse mammary tumor virus integration site family pathway

Year:  2015        PMID: 26622584      PMCID: PMC4509054          DOI: 10.3892/ol.2015.3291

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  24 in total

1.  Beta-catenin expression in relation to genetic instability and prognosis in colorectal cancer.

Authors:  Ann Mårtensson; Ake Oberg; Andreas Jung; Kristina Cederquist; Roger Stenling; Richard Palmqvist
Journal:  Oncol Rep       Date:  2007-02       Impact factor: 3.906

2.  A comparative study of the expression of Wnt-1, WISP-1, survivin and cyclin-D1 in colorectal carcinoma.

Authors:  Tin Oo Khor; Yunus A Gul; Hairuszah Ithnin; Heng Fong Seow
Journal:  Int J Colorectal Dis       Date:  2005-07-22       Impact factor: 2.571

3.  Tumor dedifferentiation: an important step in tumor invasion.

Authors:  H Gabbert; R Wagner; R Moll; C D Gerharz
Journal:  Clin Exp Metastasis       Date:  1985 Oct-Dec       Impact factor: 5.150

Review 4.  Dysregulation of Wnt/β-catenin signaling in gastrointestinal cancers.

Authors:  Bryan D White; Andy J Chien; David W Dawson
Journal:  Gastroenterology       Date:  2011-12-08       Impact factor: 22.682

5.  Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma.

Authors:  V Korinek; N Barker; P J Morin; D van Wichen; R de Weger; K W Kinzler; B Vogelstein; H Clevers
Journal:  Science       Date:  1997-03-21       Impact factor: 47.728

6.  Nuclear overexpression of the oncoprotein beta-catenin in colorectal cancer is localized predominantly at the invasion front.

Authors:  T Brabletz; A Jung; K Hermann; K Günther; W Hohenberger; T Kirchner
Journal:  Pathol Res Pract       Date:  1998       Impact factor: 3.250

7.  Heterogeneity of breast cancer metastases: comparison of therapeutic target expression and promoter methylation between primary tumors and their multifocal metastases.

Authors:  Julie M Wu; Mary Jo Fackler; Marc K Halushka; Diana W Molavi; M Evangeline Taylor; Wei Wen Teo; Constance Griffin; John Fetting; Nancy E Davidson; Angelo M De Marzo; Jessica L Hicks; Dhananjay Chitale; Marc Ladanyi; Saraswati Sukumar; Pedram Argani
Journal:  Clin Cancer Res       Date:  2008-04-01       Impact factor: 12.531

8.  Expression of Wnt ligands and Frizzled receptors in colonic mucosa and in colon carcinoma.

Authors:  R F Holcombe; J L Marsh; M L Waterman; F Lin; T Milovanovic; T Truong
Journal:  Mol Pathol       Date:  2002-08

9.  Molecular analysis of APC promoter methylation and protein expression in colorectal cancer metastasis.

Authors:  Jie Chen; Christoph Röcken; Cathy Lofton-Day; Hans-Ulrich Schulz; Oliver Müller; Nadine Kutzner; Peter Malfertheiner; Matthias P A Ebert
Journal:  Carcinogenesis       Date:  2004-09-16       Impact factor: 4.944

10.  Prognostic significance of Wnt-1, β-catenin and E-cadherin expression in advanced colorectal carcinoma.

Authors:  Aleksandra Stanczak; Rafal Stec; Lubomir Bodnar; Wojciech Olszewski; Marzena Cichowicz; Wojciech Kozlowski; Cezary Szczylik; Tadeusz Pietrucha; Maciej Wieczorek; Monika Lamparska-Przybysz
Journal:  Pathol Oncol Res       Date:  2011-06-16       Impact factor: 3.201

View more
  3 in total

Review 1.  Systematic review of the old and new concepts in the epithelial-mesenchymal transition of colorectal cancer.

Authors:  Simona Gurzu; Camelia Silveanu; Annamaria Fetyko; Vlad Butiurca; Zsolt Kovacs; Ioan Jung
Journal:  World J Gastroenterol       Date:  2016-08-14       Impact factor: 5.742

2.  PS341 inhibits hepatocellular and colorectal cancer cells through the FOXO3/CTNNB1 signaling pathway.

Authors:  Zhao Yang; Shengwu Liu; Mingao Zhu; Hong Zhang; Ji Wang; Qian Xu; Kaisu Lin; Xiumin Zhou; Min Tao; Chong Li; Hong Zhu
Journal:  Sci Rep       Date:  2016-02-26       Impact factor: 4.379

3.  HK3 overexpression associated with epithelial-mesenchymal transition in colorectal cancer.

Authors:  Elena A Pudova; Anna V Kudryavtseva; Maria S Fedorova; Andrew R Zaretsky; Dmitry S Shcherbo; Elena N Lukyanova; Anatoly Y Popov; Asiya F Sadritdinova; Ivan S Abramov; Sergey L Kharitonov; George S Krasnov; Kseniya M Klimina; Nadezhda V Koroban; Nadezhda N Volchenko; Kirill M Nyushko; Nataliya V Melnikova; Maria A Chernichenko; Dmitry V Sidorov; Boris Y Alekseev; Marina V Kiseleva; Andrey D Kaprin; Alexey A Dmitriev; Anastasiya V Snezhkina
Journal:  BMC Genomics       Date:  2018-02-09       Impact factor: 3.969

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.